The Health and Human Services Committee voted that LD 2144 'ought to pass as amended,' advancing a resolve to create an 11-member working group to review mental-health and wellness resources for Maine's heritage industries and recommend funding and service models; the group must report by Dec. 1, 2026.

Supporters said HB2550 would add needed transparency to the federal 340B drug‑pricing program so policymakers can see whether savings reach vulnerable patients; hospitals and rural pharmacists called the measure duplicative, one‑sided and administratively burdensome.